[Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D002233:Carbocysteine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D002434:Cefadroxil; D002506:Cephalexin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D003545:Cysteine / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D002434:Cefadroxil; D002233:Carbocysteine; D003545:Cysteine; D002506:Cephalexin
Studio sull'assorbimento, sull'eliminazione e sulla efficacia clinica di una nuova associazione antibiotico-mucolitica per via orale.